Instem
World-leading information solutions provider for life sciences r&d their software applications accelerate drug and chemical.
Launch date
Employees
Market cap
CAD341m
Enterprise valuation
CAD329m (Public information from Nov 2023)
Share price
£8.2834 INS.L
Conshohocken Pennsylvania (HQ)
Financials
Estimates*
GBP | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Revenues | 25.7m | 28.2m | 46.0m | 58.9m |
% growth | - | 10 % | 63 % | 28 % |
EBITDA | 1.5m | 5.4m | 8.3m | 11.6m |
% EBITDA margin | 6 % | 19 % | 18 % | 20 % |
Profit | (<1m) | 2.3m | 1.7m | 4.7m |
% profit margin | (4 %) | 8 % | 4 % | 8 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | €2.5m | Grant |
* | £203m Valuation: £203m 3.4x EV/LTM Revenues 17.5x EV/LTM EBITDA | Acquisition | |
Total Funding | CAD3.8m |
Recent News about Instem
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Instem
EditACQUISITION by Instem Mar 2011
ACQUISITION by Instem May 2013
ACQUISITION by Instem Sep 2016
ACQUISITION by Instem Mar 2021
ACQUISITION by Instem Nov 2019
ACQUISITION by Instem Mar 2021
ACQUISITION by Instem May 2016
ACQUISITION by Instem Sep 2021